Erin K. Brenner, Chief Product Development Officer at Pear Therapeutics, Inc. (PEAR), sold 8,690 shares at $1.13 ($10K) on 2023-01-20, disclosed to the SEC on 2023-01-24.
Open-market sale of $10k PEAR by Chief Product Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.